This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Ritecare Medical Products Selects Authentidate's Inscrybe Healthcare To Enhance Referral Management

BERKELEY HEIGHTS, N.J., March 3, 2011 (GLOBE NEWSWIRE) -- Authentidate Holding Corp. (Nasdaq:ADAT), a worldwide provider of secure health information exchange, workflow management services and telehealth solutions, today announced a new customer. Ritecare Medical Products, a Brooklyn, NY based supplier of home medical equipment, has selected the Inscrybe® Healthcare referral management solution to improve its processes. Ritecare will be using Inscrybe to manage their care orders (referrals). Inscrybe provides significant processing-time reduction, simpler forms completion, and a unified information management and reporting interface.

Management at Ritecare noticed that they were spending significant amounts of time and effort obtaining physician signatures to approve referrals and related documentation as well as for their office staff to manage the paper-intensive process manually. As a result, these delays are slowing down the reimbursement from insurers. Ritecare chose Inscrybe because of its proven ability to standardize and automate the manual tasks associated with the processing of referrals for home medical equipment providers.

Mayer Zarchi, President of Ritecare, noted, "Inscrybe will enable us to enhance our customer service by offering our referring physicians various communications options, including secure electronic signature and scheduled fax delivery, depending on their preferences. We expect to shorten our current referral approval cycle while improving our ability to manage the process. In addition, Inscrybe offers us a scalable solution as our business grows."

Marcus Wagstaff, National Sales Director for Authentidate, said, "We welcome Ritecare to the growing Inscrybe community of homecare organizations. Inscrybe is designed to enhance referral management, which makes it uniquely suited to meet Ritecare's needs for streamlining referral processing with referring physicians while providing Ritecare with improved management controls."

About Ritecare Medical Products

Founded in 1995, Ritecare has provided affordable quality solutions for all of one's home healthcare needs, with a full range of medical equipment and supplies. Ritecare has strived to become a leader in its industry quite often accomplishing what several of the larger organizations have been unable to accomplish. Ritecare maintains a one-on-one relationship with its customers and makes every effort to keep open the lines of communication giving our patients a sense of security and confidence in an otherwise troublesome time. Ritecare is also Joint Commission Accredited (JACHO). For additional information, go to www.ritecaremedical.com . About Authentidate Holding Corp.

Authentidate Holding Corp. is a worldwide provider of secure health information exchange, workflow management services and telehealth solutions. The company's software and web-based services enable healthcare organizations and other enterprises to increase revenues, reduce costs and enhance patient care by eliminating paper and manual work steps from clinical and administrative processes. The web-based services are delivered as Software as a Service (SaaS), and only require that customers have an Internet connection and web browser. The company's healthcare customers and users include leading homecare companies, health systems and physician groups. These organizations utilize the company's products and services to coordinate care for patients outside of acute-care.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,698.18 -77.94 -0.44%
S&P 500 2,059.69 -8.20 -0.40%
NASDAQ 4,880.2280 -20.6570 -0.42%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs